Loading…

ResMed completed the acquisition of Ectosense, maker of the NightOwl cloud-connected home sleep test device. The deal expands ResMed's diagnostic portfolio for sleep apnea.
“We believe Ectosense's digital and easy-to-use solutions in the hands of both sleep lab technicians and consumers worldwide can help significantly increase diagnoses, as well as general awareness of this highly prevalent, 100% treatable disease.”sleepreviewmag.com
Summarized from public sources; check the original articles before acting on it.